 Jason Tregellas
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 34 | 2024 | 433 | 9.870 |
Why?
| | Brain | 49 | 2024 | 2596 | 6.730 |
Why?
| | Magnetic Resonance Imaging | 65 | 2024 | 3351 | 5.850 |
Why?
| | Brain Mapping | 39 | 2023 | 562 | 4.690 |
Why?
| | Nerve Net | 19 | 2024 | 249 | 4.470 |
Why?
| | Nicotinic Agonists | 9 | 2019 | 125 | 3.220 |
Why?
| | Sensory Gating | 6 | 2024 | 42 | 3.110 |
Why?
| | Nicotine | 10 | 2017 | 303 | 2.990 |
Why?
| | Schizophrenic Psychology | 9 | 2019 | 93 | 2.670 |
Why?
| | Neural Pathways | 12 | 2024 | 290 | 2.540 |
Why?
| | Hippocampus | 13 | 2024 | 786 | 2.470 |
Why?
| | Connectome | 5 | 2024 | 83 | 2.330 |
Why?
| | Cerebral Cortex | 15 | 2020 | 407 | 2.050 |
Why?
| | Feeding Behavior | 9 | 2023 | 624 | 2.030 |
Why?
| | Obesity | 17 | 2024 | 2851 | 1.990 |
Why?
| | Energy Intake | 9 | 2019 | 460 | 1.860 |
Why?
| | Image Processing, Computer-Assisted | 22 | 2019 | 739 | 1.810 |
Why?
| | Hunger | 7 | 2023 | 39 | 1.750 |
Why?
| | Overweight | 6 | 2020 | 524 | 1.700 |
Why?
| | Psychotic Disorders | 4 | 2024 | 152 | 1.670 |
Why?
| | Antipsychotic Agents | 4 | 2024 | 194 | 1.610 |
Why?
| | Attention | 8 | 2016 | 438 | 1.570 |
Why?
| | Epilepsies, Partial | 2 | 2021 | 44 | 1.400 |
Why?
| | Auditory Perception | 5 | 2014 | 109 | 1.370 |
Why?
| | Drug Resistant Epilepsy | 2 | 2021 | 77 | 1.320 |
Why?
| | Cues | 7 | 2022 | 320 | 1.320 |
Why?
| | Electroencephalography | 6 | 2024 | 387 | 1.280 |
Why?
| | Food | 5 | 2022 | 170 | 1.270 |
Why?
| | Evoked Potentials, Auditory | 6 | 2015 | 176 | 1.240 |
Why?
| | Adult | 70 | 2024 | 35595 | 1.180 |
Why?
| | Acoustic Stimulation | 9 | 2016 | 321 | 1.120 |
Why?
| | Bipolar Disorder | 3 | 2024 | 232 | 1.110 |
Why?
| | Appetite Regulation | 5 | 2019 | 29 | 1.110 |
Why?
| | Appetite | 9 | 2023 | 60 | 1.090 |
Why?
| | Visual Perception | 7 | 2013 | 162 | 1.090 |
Why?
| | Epilepsy | 2 | 2021 | 314 | 1.050 |
Why?
| | Male | 75 | 2024 | 63544 | 1.030 |
Why?
| | Psychomotor Performance | 6 | 2016 | 312 | 1.010 |
Why?
| | Cognition | 4 | 2019 | 1098 | 1.000 |
Why?
| | Reward | 7 | 2024 | 240 | 1.000 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 329 | 1.000 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2015 | 379 | 1.000 |
Why?
| | Sex Characteristics | 4 | 2023 | 723 | 0.990 |
Why?
| | Executive Function | 3 | 2019 | 420 | 0.990 |
Why?
| | Female | 74 | 2024 | 68561 | 0.940 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 5 | 2019 | 100 | 0.940 |
Why?
| | Humans | 96 | 2024 | 129705 | 0.930 |
Why?
| | Neurons | 6 | 2017 | 1428 | 0.890 |
Why?
| | Prefrontal Cortex | 6 | 2013 | 293 | 0.870 |
Why?
| | Neuroimaging | 3 | 2020 | 273 | 0.830 |
Why?
| | Benzylidene Compounds | 3 | 2016 | 18 | 0.810 |
Why?
| | Single-Blind Method | 8 | 2017 | 275 | 0.790 |
Why?
| | Cerebellum | 4 | 2013 | 216 | 0.790 |
Why?
| | Weight Gain | 3 | 2024 | 505 | 0.790 |
Why?
| | Headache | 1 | 2023 | 138 | 0.770 |
Why?
| | Pursuit, Smooth | 5 | 2010 | 19 | 0.760 |
Why?
| | Eating | 4 | 2023 | 367 | 0.740 |
Why?
| | Cross-Over Studies | 9 | 2016 | 524 | 0.720 |
Why?
| | Satiation | 4 | 2019 | 26 | 0.700 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 323 | 0.700 |
Why?
| | Electrocorticography | 1 | 2020 | 13 | 0.690 |
Why?
| | Sensation Disorders | 2 | 2013 | 31 | 0.690 |
Why?
| | Cholinergic Agents | 3 | 2016 | 15 | 0.680 |
Why?
| | Noise | 2 | 2012 | 72 | 0.680 |
Why?
| | Neurovascular Coupling | 1 | 2019 | 6 | 0.670 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.670 |
Why?
| | Magnetoencephalography | 1 | 2020 | 119 | 0.660 |
Why?
| | Cognition Disorders | 5 | 2019 | 496 | 0.640 |
Why?
| | Middle Aged | 34 | 2024 | 31103 | 0.630 |
Why?
| | Pyridines | 3 | 2016 | 472 | 0.630 |
Why?
| | Exercise | 4 | 2017 | 1931 | 0.610 |
Why?
| | Oxygen | 10 | 2017 | 921 | 0.600 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 256 | 0.590 |
Why?
| | Food Preferences | 2 | 2016 | 112 | 0.570 |
Why?
| | Thalamus | 2 | 2009 | 79 | 0.560 |
Why?
| | Reaction Time | 7 | 2015 | 408 | 0.550 |
Why?
| | Hemodynamics | 2 | 2019 | 1097 | 0.540 |
Why?
| | Antiparkinson Agents | 1 | 2016 | 28 | 0.530 |
Why?
| | Memory, Short-Term | 1 | 2019 | 255 | 0.530 |
Why?
| | Analysis of Variance | 7 | 2017 | 1288 | 0.510 |
Why?
| | Parkinson Disease | 2 | 2023 | 408 | 0.510 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 381 | 0.510 |
Why?
| | Diet, Ketogenic | 1 | 2015 | 34 | 0.500 |
Why?
| | Repetition Priming | 1 | 2015 | 8 | 0.490 |
Why?
| | Motor Activity | 2 | 2019 | 670 | 0.490 |
Why?
| | Nutrition Policy | 1 | 2015 | 56 | 0.480 |
Why?
| | Neuropsychological Tests | 10 | 2023 | 996 | 0.470 |
Why?
| | Limbic System | 2 | 2015 | 46 | 0.470 |
Why?
| | Leptin | 2 | 2012 | 218 | 0.450 |
Why?
| | Clozapine | 1 | 2014 | 20 | 0.450 |
Why?
| | Endophenotypes | 1 | 2013 | 18 | 0.430 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 66 | 0.430 |
Why?
| | Fingers | 1 | 2013 | 87 | 0.420 |
Why?
| | Brain Waves | 1 | 2013 | 30 | 0.420 |
Why?
| | Semantics | 2 | 2013 | 100 | 0.420 |
Why?
| | Behavior Therapy | 1 | 2015 | 240 | 0.410 |
Why?
| | Body Mass Index | 6 | 2023 | 2246 | 0.410 |
Why?
| | Frontal Lobe | 4 | 2016 | 146 | 0.410 |
Why?
| | Young Adult | 16 | 2024 | 12363 | 0.400 |
Why?
| | Dronabinol | 1 | 2014 | 166 | 0.380 |
Why?
| | Efficiency | 1 | 2012 | 96 | 0.380 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 525 | 0.370 |
Why?
| | Patient Compliance | 1 | 2015 | 566 | 0.360 |
Why?
| | Photic Stimulation | 7 | 2016 | 239 | 0.360 |
Why?
| | Hallucinations | 1 | 2010 | 30 | 0.350 |
Why?
| | Autistic Disorder | 3 | 2009 | 184 | 0.350 |
Why?
| | Space Perception | 1 | 2010 | 72 | 0.330 |
Why?
| | Thinking | 2 | 2009 | 57 | 0.330 |
Why?
| | Functional Neuroimaging | 4 | 2019 | 73 | 0.320 |
Why?
| | Functional Laterality | 4 | 2013 | 216 | 0.320 |
Why?
| | Statistics as Topic | 4 | 2017 | 308 | 0.310 |
Why?
| | Urbanization | 1 | 2009 | 25 | 0.310 |
Why?
| | Nutritional Status | 1 | 2011 | 327 | 0.310 |
Why?
| | Reproducibility of Results | 4 | 2023 | 3054 | 0.300 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 1969 | 0.300 |
Why?
| | Body Weight | 1 | 2012 | 935 | 0.300 |
Why?
| | Eye Movements | 2 | 2010 | 58 | 0.280 |
Why?
| | Anorexia Nervosa | 3 | 2014 | 71 | 0.280 |
Why?
| | Case-Control Studies | 7 | 2017 | 3363 | 0.280 |
Why?
| | Hyperphagia | 3 | 2019 | 33 | 0.280 |
Why?
| | Child | 9 | 2021 | 20963 | 0.260 |
Why?
| | Decision Making | 1 | 2013 | 842 | 0.260 |
Why?
| | Taste | 3 | 2014 | 214 | 0.240 |
Why?
| | Computer Graphics | 2 | 2015 | 42 | 0.230 |
Why?
| | Social Behavior | 1 | 2006 | 287 | 0.220 |
Why?
| | Ocular Motility Disorders | 1 | 2004 | 26 | 0.220 |
Why?
| | Animals | 9 | 2019 | 34733 | 0.210 |
Why?
| | Echo-Planar Imaging | 1 | 2002 | 18 | 0.210 |
Why?
| | Gyrus Cinguli | 4 | 2007 | 78 | 0.200 |
Why?
| | Child Development Disorders, Pervasive | 2 | 2013 | 61 | 0.200 |
Why?
| | Atrophy | 3 | 2023 | 165 | 0.190 |
Why?
| | Learning | 1 | 2006 | 381 | 0.190 |
Why?
| | Adolescent | 9 | 2024 | 20355 | 0.190 |
Why?
| | Biomarkers | 4 | 2019 | 3893 | 0.190 |
Why?
| | Risk | 1 | 2024 | 871 | 0.180 |
Why?
| | Smoking | 2 | 2007 | 1507 | 0.180 |
Why?
| | Maternal Inheritance | 1 | 2020 | 15 | 0.180 |
Why?
| | Organ Size | 3 | 2012 | 448 | 0.170 |
Why?
| | Fasting | 4 | 2019 | 266 | 0.170 |
Why?
| | Weight Loss | 2 | 2019 | 727 | 0.170 |
Why?
| | Rest | 1 | 2020 | 121 | 0.170 |
Why?
| | Neural Inhibition | 2 | 2015 | 151 | 0.170 |
Why?
| | Child Development | 1 | 2024 | 452 | 0.170 |
Why?
| | Parietal Lobe | 2 | 2013 | 47 | 0.160 |
Why?
| | Thinness | 2 | 2011 | 89 | 0.160 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2019 | 55 | 0.160 |
Why?
| | Substance-Related Disorders | 3 | 2013 | 1023 | 0.160 |
Why?
| | Diet, Reducing | 1 | 2019 | 83 | 0.150 |
Why?
| | Seizures | 1 | 2021 | 396 | 0.150 |
Why?
| | Drug Users | 2 | 2016 | 44 | 0.150 |
Why?
| | Energy Metabolism | 2 | 2014 | 837 | 0.150 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 250 | 0.150 |
Why?
| | Food Analysis | 1 | 2017 | 20 | 0.150 |
Why?
| | Longitudinal Studies | 2 | 2023 | 2670 | 0.150 |
Why?
| | Temporal Lobe | 2 | 2020 | 83 | 0.140 |
Why?
| | Mice | 4 | 2015 | 16585 | 0.140 |
Why?
| | Gastric Bypass | 1 | 2019 | 107 | 0.140 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 5396 | 0.140 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 173 | 0.140 |
Why?
| | Tobacco Use Disorder | 1 | 2019 | 242 | 0.140 |
Why?
| | Child, Preschool | 3 | 2020 | 10565 | 0.130 |
Why?
| | Levodopa | 1 | 2016 | 28 | 0.130 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 8 | 0.130 |
Why?
| | Cerebrovascular Circulation | 2 | 2009 | 224 | 0.130 |
Why?
| | Social Control, Informal | 2 | 2013 | 20 | 0.130 |
Why?
| | Basal Metabolism | 1 | 2016 | 57 | 0.130 |
Why?
| | Aversive Therapy | 1 | 2015 | 3 | 0.120 |
Why?
| | Dietary Fiber | 1 | 2016 | 52 | 0.120 |
Why?
| | Lost to Follow-Up | 1 | 2015 | 22 | 0.120 |
Why?
| | Ketones | 1 | 2015 | 47 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1849 | 0.120 |
Why?
| | Hormones | 1 | 2016 | 139 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 5410 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 375 | 0.120 |
Why?
| | Choice Behavior | 1 | 2016 | 160 | 0.120 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 259 | 0.120 |
Why?
| | Dietary Proteins | 1 | 2016 | 133 | 0.120 |
Why?
| | Administration, Cutaneous | 1 | 2014 | 130 | 0.120 |
Why?
| | Sweetening Agents | 1 | 2014 | 38 | 0.120 |
Why?
| | Time Factors | 3 | 2015 | 6593 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2021 | 10299 | 0.110 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 5 | 0.110 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 62 | 0.110 |
Why?
| | Computer Simulation | 2 | 2019 | 947 | 0.110 |
Why?
| | Gamma Rhythm | 1 | 2013 | 5 | 0.110 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 182 | 0.110 |
Why?
| | Visual Cortex | 2 | 2005 | 67 | 0.110 |
Why?
| | Regression Analysis | 4 | 2019 | 992 | 0.110 |
Why?
| | Psycholinguistics | 1 | 2013 | 20 | 0.100 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 279 | 0.100 |
Why?
| | Symptom Assessment | 1 | 2014 | 127 | 0.100 |
Why?
| | Satiety Response | 1 | 2012 | 8 | 0.100 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 306 | 0.100 |
Why?
| | Heart Rate | 1 | 2017 | 808 | 0.100 |
Why?
| | Drug Discovery | 1 | 2013 | 131 | 0.100 |
Why?
| | Drug Interactions | 1 | 2014 | 371 | 0.100 |
Why?
| | Blood Glucose | 2 | 2019 | 2090 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 370 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 176 | 0.100 |
Why?
| | Body Composition | 1 | 2016 | 657 | 0.100 |
Why?
| | Aged | 3 | 2019 | 22113 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5050 | 0.100 |
Why?
| | Insulin | 2 | 2019 | 2313 | 0.100 |
Why?
| | Fornix, Brain | 1 | 2011 | 6 | 0.090 |
Why?
| | Health Behavior | 1 | 2017 | 755 | 0.090 |
Why?
| | Conduct Disorder | 1 | 2013 | 198 | 0.090 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 42 | 0.090 |
Why?
| | Subliminal Stimulation | 1 | 2010 | 2 | 0.090 |
Why?
| | Sensation | 1 | 2011 | 49 | 0.090 |
Why?
| | Marijuana Abuse | 1 | 2014 | 230 | 0.090 |
Why?
| | Parents | 2 | 2012 | 1311 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 544 | 0.090 |
Why?
| | Algorithms | 2 | 2019 | 1632 | 0.090 |
Why?
| | Speech Perception | 1 | 2012 | 81 | 0.090 |
Why?
| | Infant | 1 | 2024 | 9097 | 0.090 |
Why?
| | Pregnancy | 2 | 2020 | 6273 | 0.090 |
Why?
| | Exercise Test | 1 | 2013 | 620 | 0.090 |
Why?
| | Reference Values | 3 | 2008 | 792 | 0.090 |
Why?
| | Models, Statistical | 1 | 2014 | 632 | 0.080 |
Why?
| | Facial Expression | 1 | 2010 | 69 | 0.080 |
Why?
| | Blood Pressure | 1 | 2017 | 1747 | 0.080 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 121 | 0.080 |
Why?
| | Outpatients | 1 | 2012 | 366 | 0.080 |
Why?
| | Diet | 2 | 2017 | 1214 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4471 | 0.080 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 73 | 0.080 |
Why?
| | Corpus Striatum | 1 | 2010 | 153 | 0.080 |
Why?
| | Artifacts | 2 | 2007 | 124 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2075 | 0.070 |
Why?
| | Arousal | 1 | 2009 | 151 | 0.070 |
Why?
| | Family | 1 | 2012 | 655 | 0.070 |
Why?
| | Genotype | 2 | 2010 | 1836 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 53 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2009 | 1871 | 0.070 |
Why?
| | Visual Fields | 2 | 2005 | 87 | 0.070 |
Why?
| | Nerve Fibers | 1 | 2007 | 89 | 0.070 |
Why?
| | Communication Disorders | 1 | 2006 | 10 | 0.070 |
Why?
| | Aggression | 1 | 2009 | 193 | 0.070 |
Why?
| | Stereotyped Behavior | 1 | 2006 | 19 | 0.070 |
Why?
| | Auditory Cortex | 1 | 2007 | 40 | 0.070 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 234 | 0.070 |
Why?
| | Postprandial Period | 2 | 2019 | 104 | 0.070 |
Why?
| | Hypothalamus | 1 | 2007 | 143 | 0.070 |
Why?
| | Rats | 1 | 2015 | 5244 | 0.070 |
Why?
| | Prospective Studies | 2 | 2017 | 7130 | 0.070 |
Why?
| | Intelligence | 1 | 2006 | 128 | 0.060 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 12 | 0.060 |
Why?
| | Judgment | 1 | 2006 | 57 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 536 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4016 | 0.060 |
Why?
| | Amygdala | 2 | 2016 | 182 | 0.060 |
Why?
| | Visual Pathways | 1 | 2005 | 50 | 0.060 |
Why?
| | Breakfast | 2 | 2016 | 15 | 0.060 |
Why?
| | Pain | 1 | 2010 | 770 | 0.060 |
Why?
| | Area Under Curve | 1 | 2005 | 287 | 0.060 |
Why?
| | Head | 1 | 2004 | 96 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2007 | 876 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1195 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2071 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 51 | 0.050 |
Why?
| | Risk Factors | 2 | 2017 | 9832 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2020 | 14669 | 0.050 |
Why?
| | Movement | 1 | 2004 | 269 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2019 | 1165 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2013 | 88 | 0.040 |
Why?
| | Peptide YY | 1 | 2019 | 16 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 253 | 0.040 |
Why?
| | Ghrelin | 1 | 2019 | 36 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 426 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 113 | 0.040 |
Why?
| | Models, Neurological | 1 | 2019 | 233 | 0.030 |
Why?
| | Language | 1 | 2019 | 288 | 0.030 |
Why?
| | Lunch | 1 | 2016 | 7 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 604 | 0.030 |
Why?
| | Taste Perception | 1 | 2014 | 23 | 0.030 |
Why?
| | Machine Learning | 1 | 2019 | 419 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 143 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 20 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 725 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1212 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 186 | 0.020 |
Why?
| | Sucrose | 1 | 2012 | 93 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2012 | 104 | 0.020 |
Why?
| | Anisotropy | 1 | 2011 | 69 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 94 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3063 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2008 | 9 | 0.020 |
Why?
| | Temperance | 1 | 2008 | 13 | 0.020 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 36 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4939 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 65 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 110 | 0.020 |
Why?
| | Alcohol-Related Disorders | 1 | 2008 | 115 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1981 | 0.020 |
Why?
| | Chewing Gum | 1 | 2004 | 9 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2008 | 559 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 47 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2005 | 298 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 643 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 335 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 235 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 503 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2272 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 790 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2002 | 38 | 0.010 |
Why?
|
|
Tregellas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|